Doose Syndrome Treatment Market Future Trend, Growth Rate, Opportunity and Industry Analysis till 2030
T he global Doose Syndrome Treatment Market experienced significant growth in 2021 and is expected to continue expanding rapidly throughout the forecast period. The growth of the market is primarily driven by the increasing prevalence of Doose syndrome, a rise in the geriatric population, and investments in research and development. However, the market is also affected negatively by factors such as a lack of awareness among the population and the challenging nature of treating the disorder. Doose syndrome, also known as idiopathic generalized myoclonic astatic epilepsy (MAE), is characterized by the emergence of myoclonic seizures and/or myoclonic astatic seizures. Several frequently occurring monogenic causes include mutations in genes such as SLC6A1, CHD2, and AP2M1. The onset of seizures usually occurs between the ages of 2 and 5 years. Electroencephalogram (EEG) readings typically show a background of 4-7 Hz accompanied by bilaterally synchronous, regular and irregular 2-3 Hz sp...